In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) looks set to start the week with a decline. At the time of writing, the benchmark index is down 0.3% to 7,280.8 points.
Four ASX shares that have not let that hold them back are listed below. Here’s why they are pushing higher:
Australian Clinical Labs Ltd (ASX: ACL)
The Australian Clinical Labs share price is up 2.5% to $5.05. This morning the pathology company announced the successful completion of the acquisition of Medlab Pathology for $70 million. It is a leading Australian privately-owned independent pathology provider, with two laboratories and 288 collection centres across NSW and QLD.
Humm Group Ltd (ASX: HUM)
The Humm share price has jumped 20% to 89 cents. This morning the financial services company revealed that it has received approaches from third parties to acquire all or part of it. No details on the approaches have been provided. However, the Humm Board intends to engage with these potential suitors to determine whether their proposals are capable of becoming definitive offers.
Neometals Ltd (ASX: NMT)
The Neometals share price is up 1% to $1.05. Earlier today Neometals advised that its joint venture company, Primobius, has successfully commissioned its commercial shredding plant in Hilchenbach, Germany. From early next year, up to 10 tonnes per day of battery-grade metal sulphate chemicals will be able to be safely recycled into new battery production.
Viva Energy Group Ltd (ASX: VEA)
The Viva Energy share price is up 3.5% to $2.23. This follows the release of guidance for FY 2021 from the fuel retailer. According to the release, the company expects its operating earnings to almost double to between $470 million and $490 million. Viva achieved strong fuel sales growth across both Retail and Commercial segments in FY 2021.
The post Why Australian Clinical Labs, Humm, Neometals, and Viva Energy are rising appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of August 16th 2021
More reading
- Neometals (ASX:NMT) share price jumps on battery recycling update
- ASX 200 (ASX:XJO) midday update: Magellan shares crash 28%, CIMIC tumbles
- Why is the Humm (ASX:HUM) share price jumping 16% today?
- ASX shares that could be impacted by AdBlue shortage
- Here’s why the Neometals (ASX:NMT) share price is surging 6% today
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Australian Clinical Labs Limited and Humm Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/3p7t7El
Leave a Reply